Institutional Ownership
Coeptis Therapeutics Hldgs I
CUSIP 19207A207COM NEWQ1 2026
13D / 13G Filings
1
Schedule 13D/13G on record
Beneficial Filers
1
Distinct reporting persons
Largest Stake
6.3%
Max % of class reported
Institutional Holders
9
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
1 filings · latest Jan 30, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Jan 30, 2026 | The Vanguard Group | 13G | 6.3% | 339.5K | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Geode Capital Management, LLC | 53.1K | $596.1K |
| 2 | State Street Corp | 26.8K | $301.0K |
| 3 | United Capital Financial Advisors, LLC | 20.0K | $224.4K |
| 4 | Blackrock, Inc. | 13.6K | $152.2K |
| 5 | Northern Trust Corp | 12.2K | $137.1K |
| 6 | Steward Partners Investment Advisory, LLC | 5.0K | $56.1K |
| 7 | Morgan Stanley | 201 | $2.3K |
| 8 | Osaic Holdings, Inc. | 100 | $1.1K |
| 9 | Barclays PLC | 3 | $34 |